24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage patients with otherwise limited treatment options THE ...
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage patients with otherwise limited treatment options THE ...
(RTTNews) - Silo Pharma, Inc. (SILO) on Tuesday announced positive early findings from its ongoing study evaluating the pharmacokinetics, safety, and tolerability of SP-26, a novel ketamine-based ...
Transvascular energy ablation showed a 79% response rate in reducing pancreatic cancer pain without opioids. Patients experienced a mean pain reduction of 4.96 points, equating to a 66% improvement in ...
(MENAFN- GlobeNewsWire - Nasdaq) New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage patients with ...
Autonomix Medical is focused on developing precision nerve-targeted treatments using a transvascular RF denervation platform.
Two years after implant, patients who use Abbott Laboratories' implantable spinal cord stimulators for chronic pain continue to prefer the company's proprietary stimulation pattern over traditional ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果